Nexstim

Nasdaq
MedTech

Neuronetics lists $93.5M IPO following several VC rounds

Neuronetics has begun trading on the Nasdaq with a $93.5 million IPO pricing 5.5 million shares of common stock at $17 each, under the symbol STIM.
Conor Hale Jun 29, 2018 10:15am
fda

FDA clears Nexstim’s noninvasive brain stimulator for depression

Nov 13, 2017 10:27am